Walpar Nutritions Ltd (WALPAR) is currently trading at 24.35 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Walpar Nutritions Limited is a vertically integrated manufacturer, marketer and trader of pharmaceuticals, nutraceuticals, herbal and Ayurvedic commodities, operating manufacturing facilities under FSSAI and AYUSH licences and selling through both B2C online platforms and B2B channels domestically and in export markets. Consolidated revenues for the year ended March 31, 2026 were reported at approximately Rs. 79.05 crore (7,904.97 lakhs) with consolidated expenses of Rs. 74.95 crore and profit before tax of roughly Rs. 3.88 crore, reflecting thin but positive operating profitability and an audit opinion that is unmodified. The group structure includes two wholly owned subsidiaries (Walpar Wellness Pvt. Ltd., Walpar Nutri Science Pvt. Ltd.) and a 45% associate (Pallota Nutritions Pvt. Ltd.), with significant related-party flows, inter-company loans and high intra-group sales that materially influence consolidated working capital and cashflow dynamics. Working capital intensity is notable: consolidated trade receivables (Rs. 23.45 crore), inventories (Rs. 15.26 crore) and trade payables (Rs. 22.19 crore) show the business operates with sizable receivables and inventories relative to cash holdings, while cash from operations (consolidated ~Rs. 4.68 crore) and a strengthened cash balance (Rs. 4.93 crore) indicate improving operational cash generation. The company has a documented export footprint and product registration activity across multiple countries and runs an MI Supplement division and B2C platform, which combined with ongoing R&D since 2017 signals a strategy focused on product development, international market access, and scaling manufacturing capabilities.

Over the past 52 weeks, Walpar Nutritions Ltd has traded between a low of ₹21.25 and a high of ₹50.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Walpar Nutritions Ltd has a market capitalization of approximately 22.87. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Walpar Nutritions Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 9.41 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 22.87 Cr, Walpar Nutritions Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Walpar Nutritions Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Walpar Nutritions Ltd is 9.41. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.